Literature DB >> 19377490

Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications.

Vittorio Magri1, Florian M E Wagenlehner, Emanuele Montanari, Emanuela Marras, Viviana Orlandi, Antonella Restelli, Erminio Torresani, Kurt G Naber, Gianpaolo Perletti.   

Abstract

The significance and diagnostic value of semen analysis in chronic bacterial prostatitis has been extensively debated and remains controversial. To investigate the diagnostic relevance of semen culture in the bacteriological workup of prostatitis patients, we retrospectively analyzed a clinical database of 696 symptomatic patients. All patients were routinely subjected to a four-glass test, followed by semen culture and analysis. This allowed to dissect from the database three different diagnostic scenarios, and to compare the 'two-glass' pre-/post- massage test and the standard 'four-glass' test with a 'five-glass' test (four-glass plus post-VB3 semen culture). The 'five-glass' test showed 3.6- or 6.5-fold increases in relative sensitivity and lesser reductions (-13.2% or -14.7%) in relative specificity for traditional uropathogens (TUs) compared with the four-glass or two-glass test, respectively. The area under the ROC curve and Jouden's index were increased, whereas positive and negative likelihood ratios were lower than comparators, indicating that the 'five-glass' assay may be superior in confirming the negative outcome of both standard tests. The five-, four-, and two-glass tests detected TUs (Enterobacteriaceae, Enterococci, etc.) in 120, 33, and 20 patients and unusual pathogens (Streptococci, other Gram-positive species, Mycoplasmata, and others) in 130, 56, and 45 patients, respectively. When patients were subjected to pharmacological treatment, including a combination of a fluoroquinolone and a macrolide, no differences in eradication rates were observed between groups diagnosed with different tests, irrespective of pathogen category. Eradication was associated with long-term sign/symptom remission; no significant intergroup differences in sign/symptom scores were observed throughout a 24-month off-therapy follow-up period. In conclusion, our data support the usefulness of semen analysis in the diagnostic workup of prostatitis patients when this test is used to complement the four-glass Meares and Stamey test. Improvement of microbiological assays conveys important diagnostic and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377490      PMCID: PMC3735310          DOI: 10.1038/aja.2009.5

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  41 in total

1.  Alpha-blockers for the treatment of prostatitis-like syndromes.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2006

Review 2.  The Pre and Post Massage Test (PPMT): a simple screen for prostatitis.

Authors:  J C Nickel
Journal:  Tech Urol       Date:  1997

3.  Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?

Authors:  G W Drach; W R Fair; E M Meares; T A Stamey
Journal:  J Urol       Date:  1978-08       Impact factor: 7.450

4.  Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.

Authors:  Kurt G Naber
Journal:  Int J Antimicrob Agents       Date:  2002-07       Impact factor: 5.283

5.  Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.

Authors:  J Curtis Nickel; Jim Xiang
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

6.  Semen and urine culture in the diagnosis of chronic bacterial prostatitis.

Authors:  L Zegarra Montes R Zegarra Montes; A A Sanchez Mejia; C A Loza Munarriz; E Celis Gutierrez
Journal:  Int Braz J Urol       Date:  2008 Jan-Feb       Impact factor: 1.541

Review 7.  Prostatitis.

Authors:  G J Domingue; W J Hellstrom
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  The role of unusual pathogens in prostatitis syndrome.

Authors:  Visnja Skerk; Ivan Krhen; Slavko Schonwald; Vjeran Cajic; Leo Markovinovic; Srdan Roglic; Sime Zekan; Arjana Tambic Andracevic; Vladimira Kruzic
Journal:  Int J Antimicrob Agents       Date:  2004-09       Impact factor: 5.283

9.  Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.

Authors:  Vittorio Magri; Alberto Trinchieri; Emanuele Montanari; Alberto Del Nero; Barbara Mangiarotti; Pasquale Zirpoli; Magda de Eguileor; Emanuela Marras; Isabella Ceriani; Anne Vral; Gianpaolo Perletti
Journal:  Arch Ital Urol Androl       Date:  2007-06

10.  Microflora of the seminal fluid of healthy men and men suffering from chronic prostatitis syndrome.

Authors:  Iuri B Ivanov; Michael D Kuzmin; Viktor A Gritsenko
Journal:  Int J Androl       Date:  2008-03-05
View more
  8 in total

1.  Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.

Authors:  Vittorio Magri; Emanuele Montanari; Višnja Škerk; Alemka Markotić; Emanuela Marras; Antonella Restelli; Kurt G Naber; Gianpaolo Perletti
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

2.  Role of gram-positive bacteria in chronic pelvic pain syndrome (CPPS).

Authors:  Stephen F Murphy; Jonathan F Anker; Daniel J Mazur; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Prostate       Date:  2018-09-21       Impact factor: 4.104

Review 3.  The seminal microbiome in health and disease.

Authors:  Jason M Franasiak; Reet Mändar; Signe Altmäe
Journal:  Nat Rev Urol       Date:  2019-11-15       Impact factor: 14.432

4.  Semen microbiota in normal and leukocytospermic males.

Authors:  Ye Yao; Xin-Jian Qiu; Dong-Sheng Wang; Jie-Kun Luo; Tao Tang; Yun-Hui Li; Chun-Hu Zhang; Hao Liu; Lu Zhou; Lin-Lin Zhao
Journal:  Asian J Androl       Date:  2022 Jul-Aug       Impact factor: 3.054

5.  Analysis of bacterial community using pyrosequencing in semen from patients with chronic pelvic pain syndrome: a pilot study.

Authors:  Jin Bong Choi; Seung-Ju Lee; Sang-Rim Kang; Sang-Seob Lee; Hyun-Sop Choe
Journal:  Transl Androl Urol       Date:  2020-04

Review 6.  Pharmacological Interventions for Bacterial Prostatitis.

Authors:  Situ Xiong; Xiaoqiang Liu; Wen Deng; Zhengtao Zhou; Yulei Li; Yechao Tu; Luyao Chen; Gongxian Wang; Bin Fu
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

7.  Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.

Authors:  Apurva Virmani Johri; Pranav Johri; Naomi Hoyle; Levan Pipia; Lia Nadareishvili; Dea Nizharadze
Journal:  Front Pharmacol       Date:  2021-06-10       Impact factor: 5.810

8.  Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up.

Authors:  Vittorio Magri; Emanuele Montanari; Emanuela Marras; Gianpaolo Perletti
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.